Cochrane Reviews: Tuberculosis

07 Jun 2019

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

To determine the diagnostic accuracy of Xpert MTB/RIF and Xpert Ultra for tuberculosis in adults with presumptive PTB, and for rifampicin resistance in adults with presumptive rifampicin‐resistant tuberculosis or MDR‐TB.

Cochrane Systematic Review: UPDATE

30 Apr 2019

MVA85A vaccine to enhance BCG for preventing tuberculosis

The aim of this Cochrane review was to evaluate the effectiveness and safety of using MVA85A in addition to BCG compared to using BCG alone for the prevention of tuberculosis.

Cochrane Systematic Review: NEW

20 Mar 2019

Linezolid for drug‐resistant pulmonary tuberculosis

Recent international guidelines recommend trying to include linezolid in the treatment of all patients with multi‐drug resistant tuberculosis, but there is concern about whether enough good evidence exists to tell us how well it works, what dose is best, and how safe it is for people who take it.

Cochrane Systematic Review: NEW

27 Aug 2018

Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

To find out how accurate Xpert® MTB/RIF (Xpert) is for diagnosing extrapulmonary TB and drug resistance. We included eight forms of extrapulmonary TB: tuberculous meningitis and pleural, lymph node, bone or joint, genitourinary, peritoneal, pericardial, and disseminated TB.

Cochrane Systematic Review: NEW

READ-IT

Search

Cochrane Reviews: Tuberculosis

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

MVA85A vaccine to enhance BCG for preventing tuberculosis

Linezolid for drug‐resistant pulmonary tuberculosis

Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

Contact us

Follow us